CG&D
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cell Growth & Differentiation

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Rong, S.
Right arrow Articles by Vande Woude, G. F.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Rong, S.
Right arrow Articles by Vande Woude, G. F.

Cell Growth & Differentiation, Vol 4, Issue 7 563-569, Copyright © 1993 by American Association of Cancer Research


ARTICLES

Tumorigenesis induced by coexpression of human hepatocyte growth factor and the human met protooncogene leads to high levels of expression of the ligand and receptor

S Rong, M Oskarsson, D Faletto, I Tsarfaty, JH Resau, T Nakamura, E Rosen, RF Hopkins 3d and GF Vande Woude
ABL-Basic Research Program, NCI-Frederick Cancer Research and Development Center, Maryland 21702.

We have previously shown that, in mouse NIH/3T3 cells, it is necessary to coexpress the gene for human hepatocyte growth factor/scatter factor (HGF/SFhu) with its receptor, the human met protooncogene (methu), to activate the transforming activity of the receptor (S. Rong, M. Bodescot, D. Blair, T. Nakamura, K. Mizuno, M. Park, A. Chan, S. Aaronson, and G. F. Vande Woude, Mol. Cell. Biol., 12: 5152-5158, 1992). In this study, we report that exceptionally high levels of the ligand and its receptor are expressed in tumor cell explants after several tumor passages through nude mice. Confluent tumor cells explanted after the second passage in nude mice can express 1700 units/ml/10(6) cells/72 h of scatter activity as determined in Madin-Darby canine kidney cell scatter assays. The motogenic factor produced by these cells is easily purified by heparin-Sepharose chromatography, and the purified factor efficiently induces tyrosine phosphorylation of Methu in YaOvBix2NMA human ovarian carcinoma cells. To account for the unusually high level of HGF/SFhu and Methu expression, we propose that normal levels of Methu receptor are inefficient at transducing the signal(s) required for transformation of mouse cells. Therefore, high levels of Methu receptor are required for tumorigenesis, and corresponding high levels of the ligand are required to induce the signal. Consistent with this model, endogenous mouse scatter factor is not detected in conditioned medium from cells transformed by overexpression of the Metmu receptor.


This article has been cited by other articles:


Home page
Cancer Res.Home page
S. Pennacchietti, M. Cazzanti, A. Bertotti, W. M. Rideout III, M. Han, J. Gyuris, T. Perera, P. M. Comoglio, L. Trusolino, and P. Michieli
Microenvironment-Derived HGF Overcomes Genetically Determined Sensitivity to Anti-MET Drugs
Cancer Res., November 15, 2014; 74(22): 6598 - 6609.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
X. Zhang, S. Claerhout, A. Prat, L. E. Dobrolecki, I. Petrovic, Q. Lai, M. D. Landis, L. Wiechmann, R. Schiff, M. Giuliano, et al.
A Renewable Tissue Resource of Phenotypically Stable, Biologically and Ethnically Diverse, Patient-Derived Human Breast Cancer Xenograft Models
Cancer Res., August 1, 2013; 73(15): 4885 - 4897.
[Abstract] [Full Text] [PDF]


Home page
Molecular Cancer TherapeuticsHome page
C.-F. Gao, Q. Xie, Y.-W. Zhang, Y. Su, P. Zhao, B. Cao, K. Furge, J. Sun, K. Rex, T. Osgood, et al.
Therapeutic potential of hepatocyte growth factor/scatter factor neutralizing antibodies: Inhibition of tumor growth in both autocrine and paracrine hepatocyte growth factor/scatter factor:c-Met-driven models of leiomyosarcoma
Mol. Cancer Ther., October 1, 2009; 8(10): 2803 - 2810.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
Z. Tiran, A. Oren, C. Hermesh, G. Rotman, Z. Levine, H. Amitai, T. Handelsman, M. Beiman, A. Chen, D. Landesman-Milo, et al.
A Novel Recombinant Soluble Splice Variant of Met Is a Potent Antagonist of the Hepatocyte Growth Factor/Scatter Factor-Met Pathway
Clin. Cancer Res., July 15, 2008; 14(14): 4612 - 4621.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
P. Zhao, T. Grabinski, C. Gao, R. S. Skinner, T. Giambernardi, Y. Su, E. Hudson, J. Resau, M. Gross, G. F. Vande Woude, et al.
Identification of a Met-Binding Peptide from a Phage Display Library
Clin. Cancer Res., October 15, 2007; 13(20): 6049 - 6055.
[Abstract] [Full Text] [PDF]


Home page
Molecular Cancer TherapeuticsHome page
T. D. Francone, R. G. Landmann, C.-T. Chen, M. Y. Sun, E. J. Kuntz, Z. Zeng, R. P. Dematteo, P. B. Paty, and M. R. Weiser
Novel xenograft model expressing human hepatocyte growth factor shows ligand-dependent growth of c-Met-expressing tumors
Mol. Cancer Ther., April 1, 2007; 6(4): 1460 - 1466.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
R. Leibowitz-Amit, G. Tsarfaty, Y. Abargil, G. M. Yerushalmi, J. Horev, and I. Tsarfaty
Mimp, a Mitochondrial Carrier Homologue, Inhibits Met-HGF/SF-Induced Scattering and Tumorigenicity by Altering Met-HGF/SF Signaling Pathways.
Cancer Res., September 1, 2006; 66(17): 8687 - 8697.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
M. Hecht, M. Papoutsi, H. D. Tran, J. Wilting, and L. Schweigerer
Hepatocyte Growth Factor/c-Met Signaling Promotes the Progression of Experimental Human Neuroblastomas
Cancer Res., September 1, 2004; 64(17): 6109 - 6118.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
J. G. Christensen, R. Schreck, J. Burrows, P. Kuruganti, E. Chan, P. Le, J. Chen, X. Wang, L. Ruslim, R. Blake, et al.
A Selective Small Molecule Inhibitor of c-Met Kinase Inhibits c-Met-Dependent Phenotypes in Vitro and Exhibits Cytoreductive Antitumor Activity in Vivo
Cancer Res., November 1, 2003; 63(21): 7345 - 7355.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
P. C. Ma, T. Kijima, G. Maulik, E. A. Fox, M. Sattler, J. D. Griffin, B. E. Johnson, and R. Salgia
c-MET Mutational Analysis in Small Cell Lung Cancer: Novel Juxtamembrane Domain Mutations Regulating Cytoskeletal Functions
Cancer Res., October 1, 2003; 63(19): 6272 - 6281.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
R. V. Hay, B. Cao, R. S. Skinner, L.-M. Wang, Y. Su, J. H. Resau, B. S. Knudsen, M. F. Gustafson, H.-M. Koo, G. F. V. Woude, et al.
Radioimmunoscintigraphy of Human Met-Expressing Tumor Xenografts Using Met3, a New Monoclonal Antibody
Clin. Cancer Res., September 1, 2003; 9(10): 3839s - 3844s.
[Abstract] [Full Text]


Home page
Mol. Biol. CellHome page
D. E. Hammond, S. Carter, J. McCullough, S. Urbe, G. Vande Woude, and M. J. Clague
Endosomal Dynamics of Met Determine Signaling Output
Mol. Biol. Cell, April 1, 2003; 14(4): 1346 - 1354.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
C.-N. Qian, X. Guo, B. Cao, E. J. Kort, C.-C. Lee, J. Chen, L.-M. Wang, W.-Y. Mai, H.-Q. Min, M.-H. Hong, et al.
Met Protein Expression Level Correlates with Survival in Patients with Late-stage Nasopharyngeal Carcinoma
Cancer Res., January 1, 2002; 62(2): 589 - 596.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
B. Cao, Y. Su, M. Oskarsson, P. Zhao, E. J. Kort, R. J. Fisher, L.-M. Wang, and G. F. Vande Woude
Neutralizing monoclonal antibodies to hepatocyte growth factor/scatter factor (HGF/SF) display antitumor activity in animal models
PNAS, June 19, 2001; 98(13): 7443 - 7448.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
M. Shaharabany, R. Abramovitch, T. Kushnir, G. Tsarfaty, M. Ravid-Megido, J. Horev, R. Ron, Y. Itzchak, and I. Tsarfaty
In Vivo Molecular Imaging of Met Tyrosine Kinase Growth Factor Receptor Activity in Normal Organs and Breast Tumors
Cancer Res., June 1, 2001; 61(12): 4873 - 4878.
[Abstract] [Full Text] [PDF]


Home page
J Biol ChemHome page
S.-L. Lee, R. B. Dickson, and C.-Y. Lin
Activation of Hepatocyte Growth Factor and Urokinase/Plasminogen Activator by Matriptase, an Epithelial Membrane Serine Protease
J. Biol. Chem., November 24, 2000; 275(47): 36720 - 36725.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
T. Otsuka, J. Jakubczak, W. Vieira, D. P. Bottaro, D. Breckenridge, W. J. Larochelle, and G. Merlino
Disassociation of Met-Mediated Biological Responses In Vivo: the Natural Hepatocyte Growth Factor/Scatter Factor Splice Variant NK2 Antagonizes Growth but Facilitates Metastasis
Mol. Cell. Biol., March 15, 2000; 20(6): 2055 - 2065.
[Abstract] [Full Text] [PDF]


Home page
J Biol ChemHome page
G. A. Taylor, E. Hudson, J. H. Resau, and G. F. Vande Woude
Regulation of P311 Expression by Met-Hepatocyte Growth Factor/Scatter Factor and the Ubiquitin/Proteasome System
J. Biol. Chem., February 11, 2000; 275(6): 4215 - 4219.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
C. P. Webb, C. D. Hose, S. Koochekpour, M. Jeffers, M. Oskarsson, E. Sausville, A. Monks, and G. F. Vande Woude
The Geldanamycins Are Potent Inhibitors of the Hepatocyte Growth Factor/Scatter Factor-Met-Urokinase Plasminogen Activator-Plasmin Proteolytic Network
Cancer Res., January 1, 2000; 60(2): 342 - 349.
[Abstract] [Full Text]


Home page
Mol. Cell. Biol.Home page
S. Koochekpour, M. Jeffers, P. H. Wang, C. Gong, G. A. Taylor, L. M. Roessler, R. Stearman, J. R. Vasselli, W. G. Stetler-Stevenson, W. G. Kaelin Jr., et al.
The von Hippel-Lindau Tumor Suppressor Gene Inhibits Hepatocyte Growth Factor/Scatter Factor-Induced Invasion and Branching Morphogenesis in Renal Carcinoma Cells
Mol. Cell. Biol., September 1, 1999; 19(9): 5902 - 5912.
[Abstract] [Full Text] [PDF]


Home page
Mol. Biol. CellHome page
A. Chausovsky, I. Tsarfaty, Z. Kam, Y. Yarden, B. Geiger, and A. D. Bershadsky
Morphogenetic Effects of Neuregulin (Neu Differentiation Factor) in Cultured Epithelial Cells
Mol. Biol. Cell, November 1, 1998; 9(11): 3195 - 3209.
[Abstract] [Full Text]


Home page
J. Neurosci.Home page
X.-M. Yang, J. G. Toma, S. X. Bamji, D. J. Belliveau, J. Kohn, M. Park, and F. D. Miller
Autocrine Hepatocyte Growth Factor Provides a Local Mechanism for Promoting Axonal Growth
J. Neurosci., October 15, 1998; 18(20): 8369 - 8381.
[Abstract] [Full Text] [PDF]


Home page
JCBHome page
L. Trusolino, G. Serini, G. Cecchini, C. Besati, F. S. Ambesi-Impiombato, P. C. Marchisio, and R. De Filippi
Growth Factor-dependent Activation of {alpha}v{beta}3 Integrin in Normal Epithelial Cells: Implications for Tumor Invasion
J. Cell Biol., August 24, 1998; 142(4): 1145 - 1156.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
M. Jeffers, L. Schmidt, N. Nakaigawa, C. P. Webb, G. Weirich, T. Kishida, B. Zbar, and G. F. Vande Woude
Activating mutations for the Met tyrosine kinase receptor in human cancer
PNAS, October 14, 1997; 94(21): 11445 - 11450.
[Abstract] [Full Text] [PDF]


Home page
J Biol ChemHome page
G. A. Taylor, M. Jeffers, D. A. Largaespada, N. A. Jenkins, N. G. Copeland, and G. F. V. Woude
Identification of a Novel GTPase, the Inducibly Expressed GTPase, That Accumulates in Response to Interferon {gamma}
J. Biol. Chem., August 23, 1996; 271(34): 20399 - 20405.
[Abstract] [Full Text] [PDF]


Home page
J. Cell Sci.Home page
S. Bellusci, G. Moens, J. P. Thiery, and J. Jouanneau
A scatter factor-like factor is produced by a metastatic variant of a rat bladder carcinoma cell line
J. Cell Sci., May 1, 1994; 107(5): 1277 - 1287.
[Abstract] [PDF]


Home page
ScienceHome page
I Tsarfaty, S Rong, J. Resau, S Rulong, P. da Silva, and G. Vande Woude
The Met proto-oncogene mesenchymal to epithelial cell conversion
Science, January 7, 1994; 263(5143): 98 - 101.
[Abstract] [PDF]


Home page
Cold Spring Harb Symp Quant BiolHome page
S. Rong and G.F. Vande Woude
Autocrine Mechanism for met Proto-oncogene Tumorigenicity
Cold Spring Harb Symp Quant Biol, January 1, 1994; 59(0): 629 - 636.
[Abstract] [PDF]


Home page
J Biol ChemHome page
S.-L. Lee, R. B. Dickson, and C.-Y. Lin
Activation of Hepatocyte Growth Factor and Urokinase/Plasminogen Activator by Matriptase, an Epithelial Membrane Serine Protease
J. Biol. Chem., November 24, 2000; 275(47): 36720 - 36725.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cell Growth & Differentiation
Copyright © 1993 by the American Association of Cancer Research.